Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDonating blood while taking Wegovy (semaglutide) is possible in many cases, but it depends on timing, your dose, and the criteria set by NHS Blood and Transplant. Wegovy is a prescription-only medicine that requires clinical assessment before starting — and the same careful thinking applies if you want to donate. Here is what the current guidance actually says, and what to do before you book your next appointment at the donation centre.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
NHS Blood and Transplant operates a medicine-disclosure system: every donor completes a health questionnaire before each session, and prescription medicines must be listed. Semaglutide (the active ingredient in Wegovy) should be declared every time, not just at your first donation after starting treatment. The clinical team at the donation centre will then make an individual assessment.
This is not a formality. Wegovy slows gastric emptying and can cause nausea, vomiting and dizziness, particularly around dose increases. Giving blood when you are already dehydrated or symptomatic from those effects raises the risk of a vasovagal reaction during or after donation. The donation team needs to know your current dose and how you have been tolerating it in the days before your appointment.
A practical note on timing: if you are on a monthly prescription cycle and your next pen arrives mid-month, plan your donation appointment for a period when your system has settled, not in the first week after a dose step-up. If you are wondering whether you can donate blood while on Wegovy, it is worth thinking through the timing in advance rather than on the day, whether that is a Monday order, a bank holiday or a payday-driven schedule change.
A deferral is not a refusal. NHS Blood and Transplant defers donors temporarily for a wide range of reasons, including certain medicines, recent illness and low haemoglobin. For people on Wegovy, the most common reasons a session might be deferred include: active or recent gastrointestinal side effects; signs of dehydration; or a dose change within a defined period before the appointment.
There is no published, fixed deferral window for semaglutide specifically at the time this page was written, because NHS Blood and Transplant assesses medicines individually and updates its guidance as evidence develops. That means you cannot rely on a rule of thumb shared in an online forum. The definitive answer comes from the donation centre's clinical staff, who have access to the current medicine assessment list and can weigh your individual situation.
If you are looking into related questions around lifestyle and Wegovy (for instance, whether fasting around a donation appointment is appropriate) the page on fasting while on Wegovy covers what the guidance says about eating patterns on semaglutide.
Every donation session includes an on-the-spot haemoglobin test. Wegovy does not directly lower iron levels, but reduced appetite on treatment can lead to a lower dietary intake of iron-rich foods over time. If you have been eating significantly less since starting semaglutide, it is worth monitoring whether your diet still includes adequate sources of iron (meat, fish, pulses, fortified cereals) or whether a conversation with your prescriber or GP about nutritional adequacy is sensible before you donate regularly.
NHS Blood and Transplant sets a haemoglobin minimum of 125 g/L for women and 135 g/L for men. If you fall below that on the day, donation will be deferred regardless of your medicine status. Our page on giving blood on Wegovy goes into more detail on how dehydration and GI side effects can affect your eligibility on the day, so it is worth reading before your appointment. You can read the NHS patient information for semaglutide on the NHS medicines pages for a full list of reported side effects to be aware of.
If you are already on Wegovy and want to donate regularly, the most straightforward path is to contact NHS Blood and Transplant directly and mention the medicine by name. Their helpline and online enquiry system handle medicine queries before your appointment, which saves a wasted journey. Your Wegovy prescriber can also confirm your current dose and any recent changes in a way that you can communicate clearly to the donation team.
Wegovy is a prescription-only medicine authorised by the MHRA for weight management in adults, alongside a reduced-calorie diet and increased physical activity, as set out in the NHS patient information for semaglutide. Starting or continuing treatment requires clinical assessment. For people weighing up the treatment itself (what it involves, what it costs, and whether it suits their situation) an overview of Wegovy costs in the UK is a useful reference before committing.
If you have concerns about how Wegovy might interact with other aspects of your health (including any heart-rhythm conditions) the page on Wegovy and SVT covers what is currently known. And if you want to understand the broader picture of semaglutide as a treatment, including how it is licensed and what the trial evidence shows, that is a good starting point. Decisions about donating blood are personal and should always be made with the donation centre team rather than inferred from general guidance, but being informed going in makes the conversation much easier.
If you are not yet on Wegovy and are considering it, checking your eligibility with our clinical team is the place to start. A GPhC-registered prescriber at nume (sorry, at our pharmacy) reads every consultation the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.